Donor Sites of 14q32.33 Translocations Detected by FISH
| Specific Translocations . | Partner Sites . | Disease4-150 . | Patient No. . | Karyotypic Abnormalities . |
|---|---|---|---|---|
| t(11; 14) | 11q13 | MM (G, κ) | 10 | 46,XX |
| PCL (G, κ) | 39 | 46,XY | ||
| PCL (BJ, λ) | 40 | 11q− | ||
| PCL (G, κ) | 41 | ND | ||
| PCM (G, λ) | 42 | 46,XX | ||
| t(8; 14) | 8q24 | MM (A, λ) | 1 | t(8; 14) |
| MM (BJ, κ) | 18 | 46,XY | ||
| t(14; 18) | 18q21 | MM (G, κ) | 20 | 46,XY |
| MM (G, κ) | 24 | 46,XX | ||
| t(7; 14) | 7q32.1 | MM (BJ, λ)4-150 | 11 | 14q+ |
| ins[14;der(16)] | 16q24 | MM (BJ, κ) | 2 | t(8; 22) |
| t(14;?) | NI | MM (G, κ) | 5 | 6q− |
| MM (G, κ) | 9 | Complex | ||
| MM (G, λ) | 12 | 14q+ | ||
| MM (A, λ) | 13 | ND | ||
| MM (A, κ) | 16 | ND | ||
| MM (G, κ) | 19 | Complex | ||
| MM (G, κ) | 21 | 46,XY | ||
| MM (G, λ) | 23 | 46,XX | ||
| MM (G, κ) | 25 | 46,XY | ||
| MM (G, λ) | 26 | ND | ||
| MGUS (G, λ) | 44 | +8(SCA) |
| Specific Translocations . | Partner Sites . | Disease4-150 . | Patient No. . | Karyotypic Abnormalities . |
|---|---|---|---|---|
| t(11; 14) | 11q13 | MM (G, κ) | 10 | 46,XX |
| PCL (G, κ) | 39 | 46,XY | ||
| PCL (BJ, λ) | 40 | 11q− | ||
| PCL (G, κ) | 41 | ND | ||
| PCM (G, λ) | 42 | 46,XX | ||
| t(8; 14) | 8q24 | MM (A, λ) | 1 | t(8; 14) |
| MM (BJ, κ) | 18 | 46,XY | ||
| t(14; 18) | 18q21 | MM (G, κ) | 20 | 46,XY |
| MM (G, κ) | 24 | 46,XX | ||
| t(7; 14) | 7q32.1 | MM (BJ, λ)4-150 | 11 | 14q+ |
| ins[14;der(16)] | 16q24 | MM (BJ, κ) | 2 | t(8; 22) |
| t(14;?) | NI | MM (G, κ) | 5 | 6q− |
| MM (G, κ) | 9 | Complex | ||
| MM (G, λ) | 12 | 14q+ | ||
| MM (A, λ) | 13 | ND | ||
| MM (A, κ) | 16 | ND | ||
| MM (G, κ) | 19 | Complex | ||
| MM (G, κ) | 21 | 46,XY | ||
| MM (G, λ) | 23 | 46,XX | ||
| MM (G, κ) | 25 | 46,XY | ||
| MM (G, λ) | 26 | ND | ||
| MGUS (G, λ) | 44 | +8(SCA) |
Abbreviations: NI, not identified; PCL, plasma cell leukemia; PCM, plasmacytoma; SCA, single cell abnormality; ND, not done.
Myeloma cells showed myelomonocytoid phenotype.